| Intratumoral CRP May Predict Post-Op RCC Outcomes - Renal and Urology News |
|
|
Renal and Urology News WASHINGTON, DC—Intratumoral C-reactive protein (CRP) may be a robust biomarker of prognosis in patients with local renal cell carcinoma (RCC), investigators reported at the American Urological Association 2011 annual meeting. Viraj Master, MD, PhD, |